Why is Ambey Laborator. falling/rising?

As of 26-Sep, Ambey Laboratories Ltd is experiencing a decline in its stock price, currently at 41.25, which reflects a decrease of 1.3 or 3.06%. The stock has underperformed its sector today by 0.98%. In terms of returns, over the past week, the stock has gained 0.98%, while it has shown a modest increase of 0.24% over the past month. However, year-to-date, the stock is down significantly by 35.29%, and over the past year, it has decreased by 37.02%. The stock is currently trading higher than its 100-day moving average but lower than its 5-day, 20-day, 50-day, and 200-day moving averages. Additionally, there has been a rise in investor participation, with a delivery volume increase of 11.11% against the 5-day average, indicating some interest despite the overall decline.
In the broader market context, the Sensex has declined by 2.65% over the past week, while Ambey Laboratories has shown a positive return in the same period. However, the stock's year-to-date performance is significantly worse than the Sensex, which has gained 4.27% during the same timeframe. This stark contrast highlights the challenges faced by Ambey Laboratories in attracting investor confidence compared to the broader market. The absence of specific positive or negative factors in the dashboard limits the understanding of the underlying reasons for the stock's recent movements, making it difficult to pinpoint exact catalysts for the decline.